Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	39.63B
Revenue (ttm)	8.94B
Net Income (ttm)	779.90M
Shares Out	1.49B
EPS (ttm)	0.53
PE Ratio	49.99
Forward PE	23.12
Dividend	0.25 (1.03%)
Ex-Dividend Date	Jul 10, 2025

Volume	108,536,031
Average Volume	52,487,944
Open	24.25
Previous Close	24.17
Day's Range	24.01 - 26.59
52-Week Range	13.49 - 26.59
Beta	0.35
RSI	72.81
Earnings Date	Aug 26, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. The company was founded in 1989 and is headquartered in Linhai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 9,065
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2024, SHA:600521's revenue was 9.55 billion, an increase of 14.91% compared to the previous year's 8.31 billion. Earnings were 1.12 billion, an increase of 34.74%.